In that respect, the recognition that PTHrP overexpression enhances ß-cell survival shows potential therapeutic targets for pharmaceutical agents aimed at improving the survival of ß-cells in diabetes [6]. This evidence concerns the gene PTHLH and diabetes mellitus.